DYRK1B and hepatocellular carcinoma: Combined treatment with cisplatin and the Dyrk1B inhibitor AZ191 effectively inhibited tumor growth in xenograft tumor assays in BALB/c nude mice injected with Hep3B or PLC8024 hepatocellular carcinoma cell lines [75].